ARTICLE | Clinical News
Tarceva erlotinib regulatory update
August 15, 2005 7:00 AM UTC
On Sept. 13, FDA's Oncologic Drugs Advisory Committee (ODAC) will review an sNDA for Tarceva erlotinib plus gemcitabine chemotherapy to treat first-line advanced pancreatic cancer. The sNDA has Priori...